High materiality8/10
Spyre Therapeutics price target raised to $112 from $98 at BTIG
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
BTIG raises SYRE price target to $112; current price $83.58.
- BTIG raises PT to $112.
Key facts
- 01
Target: $112
- 02
Posted price: $83.58
- 03
Analyst firm: BTIG
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.